Rocket Pharmaceuticals Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 244.4 | 244.0 | 195.5 | 168.9 | 133.8 | 80.3 | 30.2 | 40.1 | – | – | – | |
| 3.0 | 2.2 | 0.9 | 0.9 | 1.0 | 1.5 | 4.0 | 4.9 | 6.8 | 3.4 | 4.5 | 3.0 | 2.5 | 4.1 | 2.7 | 4.3 | 5.2 | 6.0 | 5.7 | 5.7 | 3.9 | 3.1 | 2.5 | 2.3 | 2.9 | 2.9 | 3.0 | 4.0 | 3.1 | 5.1 | 5.7 | 5.2 | 5.3 | 2.7 | 1.8 | 0.8 | 1.2 | 1.4 | 1.7 | 1.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 239.2 | 240.9 | 192.0 | 162.8 | 116.3 | 75.2 | 27.0 | 32.1 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 21.1 | |
| -13.1% | -22.9% | -74.3% | -73.8% | -70.5% | -37.1% | -3.8% | -3.9% | -3.7% | -8.3% | -7.6% | -10.2% | -13.7% | -7.0% | -12.9% | -8.8% | -8.3% | -3.4% | -3.7% | -4.1% | -6.6% | -9.3% | -14.4% | -16.4% | -15.1% | -13.1% | -15.2% | -13.7% | -14.0% | -8.4% | -8.3% | -10.4% | -11.6% | -17.5% | -28.9% | -74.3% | -55.1% | -49.0% | -44.5% | -43.8% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | -5.6% | -11.6% | -17.7% | -26.0% | -34.0% | -36.2% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,518.0% | -2,568.3% | -2,616.3% | -2,655.1% | -2,974.1% | -2,941.6% | -2,913.7% | -2,726.7% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,381.6% | -2,417.7% | -2,456.0% | -2,502.7% | -2,816.7% | -2,808.9% | -2,801.0% | -2,622.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,050.6% | -2,034.1% | -2,041.5% | -1,962.8% | -2,347.7% | -2,317.7% | -2,244.0% | -2,207.9% | – | – | – | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -44.7% | -58.6% | -68.7% | -71.8% | -73.6% | -61.8% | -20.1% | -27.6% | -36.3% | -38.4% | -44.4% | -32.8% | -36.5% | -25.1% | -28.8% | -33.3% | -40.8% | -27.7% | -32.3% | -33.7% | -38.2% | -37.2% | -41.2% | -49.5% | -54.3% | -45.3% | -51.7% | -61.7% | -46.7% | -49.9% | -56.5% | -65.8% | -78.3% | -55.9% | -62.6% | -72.6% | -76.8% | -80.5% | -88.0% | -4.7% | |
| -27.2% | -33.1% | -36.9% | -37.2% | -35.9% | -29.0% | -15.7% | -20.9% | -26.7% | -29.7% | -32.5% | -26.4% | -28.3% | -20.8% | -22.1% | -25.2% | -29.4% | -23.6% | -26.9% | -30.8% | -35.0% | -34.0% | -37.4% | -44.4% | -47.8% | -40.2% | -46.1% | -53.8% | -42.2% | -43.4% | -49.9% | -56.7% | -65.6% | -49.0% | -54.8% | -61.1% | -65.5% | -67.5% | -73.4% | -4.1% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -34 | 24 | 26 | 25 | 3.0 | -29 | -93 | 27 | 2.6 | -70 | -81 | -21 | -44 | -139 | -142 | -115 | -33 | -255 | -210 | -257 | -243 | -230 | -128 | -185 | -194 | -138 | -62 | -42 | -223 | -53 | -32 | -36 | -63 | -161 | -47 | -30 | -73 | -75 | -47 | -222 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -27.9 | |
| 60.7% | 56.4% | 53.6% | 51.8% | 48.8% | 46.9% | 78.3% | 75.7% | 73.7% | 77.2% | 73.1% | 80.5% | 77.3% | 82.6% | 76.7% | 75.5% | 72.1% | 85.2% | 83.3% | 91.5% | 91.6% | 91.5% | 90.8% | 89.8% | 88.0% | 88.7% | 89.1% | 87.3% | 90.4% | 87.0% | 88.4% | 86.2% | 83.8% | 87.8% | 87.5% | 84.1% | 85.2% | 83.9% | 83.4% | 87.2% | |
| 0.6 | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 | 0.5 | 0.5 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -5.65 | -6.35 | -6.39 | -6.08 | -5.53 | -4.35 | -0.95 | -1.10 | -1.30 | -1.65 | -1.74 | -1.66 | -1.68 | -1.41 | -1.50 | -1.61 | -1.79 | -2.53 | -2.52 | -2.61 | -2.91 | -2.62 | -2.66 | -2.93 | -3.01 | -3.04 | -2.99 | -3.09 | -3.06 | -2.92 | -2.67 | -2.70 | -2.74 | -2.65 | -2.34 | -2.32 | -2.16 | -2.01 | -1.87 | -0.15 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.11 | 0.11 | 0.11 | 0.09 | 0.08 | 0.08 | 0.08 | 0.00 | 0.00 | 0.00 | |
| 12.63 | 10.85 | 9.31 | 8.47 | 7.52 | 7.04 | 4.71 | 3.98 | 3.60 | 4.30 | 3.92 | 5.04 | 4.60 | 5.60 | 5.21 | 4.83 | 4.38 | 9.12 | 7.80 | 7.76 | 7.61 | 7.05 | 6.47 | 5.92 | 5.55 | 6.72 | 5.78 | 5.01 | 6.55 | 5.86 | 4.72 | 4.10 | 3.50 | 4.75 | 3.74 | 3.19 | 2.81 | 2.49 | 2.12 | 3.22 | |
| -4.99 | -5.60 | -5.95 | -5.61 | -5.07 | -3.86 | -0.72 | -0.76 | -0.92 | -1.22 | -1.34 | -1.53 | -1.60 | -1.60 | -1.81 | -1.83 | -1.90 | -1.88 | -1.63 | -1.82 | -1.97 | -2.02 | -2.28 | -2.26 | -2.42 | -2.56 | -2.60 | -2.73 | -2.87 | -2.52 | -2.24 | -2.25 | -2.15 | -2.21 | -1.93 | -1.86 | -1.82 | -1.71 | -1.60 | -1.49 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.